Chat with us, powered by LiveChat
Micro Market Research
+1-888-502-0539
US/CAN Toll Free

You are here :   Home    

Healthcare Market Research Reports

PRODUCT TITLE PUBLISHED
Tars Tars
Tars and its peer markets - Other antipsoriatics for topical use,
Upcoming
Antracen derivatives Antracen derivatives
Antracen derivatives and its peer markets - Clinical Trial Management Systems (CTMS),
Upcoming
Psoralens for topical use Psoralens for topical use
Psoralens for topical use and its peer markets - Proteomics, Digital...
Upcoming
Psoralens for systemic use Psoralens for systemic use
Psoralens for systemic use and its peer markets - Proteomics,
Upcoming
Retinoids for treatment of psoriasis Retinoids for treatment of psoriasis
Retinoids for treatment of psoriasis and its peer markets - Proteomics,
Upcoming
Tetracycline and derivatives Tetracycline and derivatives
Tetracycline and derivatives and its peer markets - Chromatography Instruments,
Upcoming
Topical Sulfonamides Topical Sulfonamides
Topical Sulfonamides and its peer markets - E-Clinical Trial Solutions,
Upcoming
Topical Antivirals Topical Antivirals
Topical Antivirals and its peer markets - Other topical chemotherapeutics,
Upcoming
Corticosteroids, weak (group I) Corticosteroids, weak (group I)
Corticosteroids, weak (group I) and its peer markets - Chromatography,
Upcoming
Corticosteroids, moderately potent (group II) Corticosteroids, moderately potent (group II)
Corticosteroids, moderately potent (group II) and its peer markets - Corticosteroids, very potent (group IV),
Upcoming
Corticosteroids, potent (group III) Corticosteroids, potent (group III)
Corticosteroids, potent (group III) and its peer markets - Chromatography Instruments,
Upcoming
Corticosteroids, very potent (group IV) Corticosteroids, very potent (group IV)
Corticosteroids, very potent (group IV) and its peer markets - Corticosteroids, moderately potent (group II),
Upcoming
Corticosteroids, weak, combinations with antiseptics Corticosteroids, weak, combinations with antiseptics
Corticosteroids, weak, combinations with antiseptics and its peer markets - Immunoassay,
Upcoming
Corticosteroids, moderately potent, combinations with antiseptics Corticosteroids, moderately potent, combinations with antiseptics
Corticosteroids, moderately potent, combinations with antiseptics and its peer markets - Proteomics,
Upcoming
Corticosteroids, potent, combinations with antiseptics Corticosteroids, potent, combinations with antiseptics
Corticosteroids, potent, combinations with antiseptics and its peer markets - Chromatography,
Upcoming
Corticosteroids, very potent, combinations with antiseptics Corticosteroids, very potent, combinations with antiseptics
Corticosteroids, very potent, combinations with antiseptics and its peer markets - Chromatography Instruments,
Upcoming
Corticosteroids, weak, combinations with antibiotics Corticosteroids, weak, combinations with antibiotics
Corticosteroids, weak, combinations with antibiotics and its peer markets - Proteomics,
Upcoming
Corticosteroids, moderately potent, combinations with antibiotics Corticosteroids, moderately potent, combinations with antibiotics
Corticosteroids, moderately potent, combinations with antibiotics and its peer markets - Wireless Health,
Upcoming
Corticosteroids, potent, combinations with antibiotics Corticosteroids, potent, combinations with antibiotics
Corticosteroids, potent, combinations with antibiotics and its peer markets - Clinical Trial Management Systems (CTMS),
Upcoming
Corticosteroids, very potent, combinations with antibiotics Corticosteroids, very potent, combinations with antibiotics
Corticosteroids, very potent, combinations with antibiotics and its peer markets - Corticosteroids, moderately potent,...
Upcoming
2985 reports | Show
Connect With Us
US/CAN : +1-888-502-0539